| Market Capitalization (Millions $) |
2,337 |
| Shares
Outstanding (Millions) |
39 |
| Employees |
37 |
| Revenues (TTM) (Millions $) |
- |
| Net Income (TTM) (Millions $) |
-76 |
| Cash Flow (TTM) (Millions $) |
4 |
| Capital Exp. (TTM) (Millions $) |
0 |
Longboard Pharmaceuticals Inc
Longboard Pharmaceuticals Inc. is a biopharmaceutical company that focuses on developing innovative treatments for neurological disorders. The company employs a unique approach that combines deep scientific expertise with cutting-edge technology to discover and develop new therapies.
Longboard Pharmaceuticals aims to address the significant unmet medical needs in neurological disorders, including Alzheimer's disease, Parkinson's disease, and other neurodegenerative conditions. The company leverages its strategic partnerships, collaborations, and in-house capabilities to advance its drug discovery and development programs.
By utilizing a multidisciplinary approach, Longboard Pharmaceuticals explores various modalities, including small molecules, gene therapies, and RNA-targeted therapeutics, to develop novel treatments. The company believes in translating breakthrough science into therapeutic solutions that can enhance the quality of life for patients suffering from neurological disorders.
Overall, Longboard Pharmaceuticals Inc. is committed to advancing the understanding and treatment of neurological diseases by leveraging cutting-edge science and technology to develop innovative and transformative therapies.
Company Address: 4275 Executive Square La Jolla 92037 CA
Company Phone Number: 789-9283 Stock Exchange / Ticker: NASDAQ LBPH
|
27.85% 